CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 71 filers reported holding CULLINAN ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,508,000 | -72.0% | 429,646 | -72.0% | 0.10% | -67.4% |
| Q2 2022 | $19,686,000 | +22.4% | 1,535,560 | 0.0% | 0.29% | +68.2% |
| Q1 2022 | $16,077,000 | -28.6% | 1,535,560 | 0.0% | 0.17% | -22.1% |
| Q4 2021 | $22,509,000 | -44.1% | 1,535,560 | -16.3% | 0.22% | -40.0% |
| Q3 2021 | $40,237,000 | -13.1% | 1,835,560 | 0.0% | 0.37% | -1.3% |
| Q2 2021 | $46,277,000 | -35.5% | 1,835,560 | 0.0% | 0.38% | -34.3% |
| Q1 2021 | $71,699,000 | – | 1,835,560 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |